2017年職稱英語考試衛(wèi)生類A級完形填空練習(xí)題8

字號:

Once-daily pill could simplify HIV treatment
    Myers Squibb and Gilead Sciences have combined many H.I.V. drugs into a single pill Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and H.I.V./AIDS,2 for example, are all treated with ____1____ of drugs. But that can mean a lot of pills to take. It would be ____2____ if drug companies combined all the medicines into a single pill, taken just once a day.
    Now, two companies say they have done that for people just ____3____ treatment for H.I.V., the virus that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences. They have ____4____ a single pill that combines three drugs currently on the market.3 Bristol-Myers Squibb sells one of them ____5____ the name of Sustiva.4 Gilead combined the ____6____, Emtriva and Viread, into a single pill in two thousand four.
    Combining drugs involves more than ____7____ issues. It also involves issues of competition ____8____ the drugs are made by different companies. The new once-daily pill is the result of ____9____ is described as the first joint venture agreement of its kind in the treatment of H.I.V.
    In January the New England Journal of Medicine5 published a study of the new pill. Researchers compared its ____10____ to6 that of the widely used combination of Sustiva and Combivir. Combivir ____11____ two drugs, AZT7 and 3TC.8 The researchers say that after one year of treatment, the new pill suppressed H.I.V. levels in more patients and with ____12____ side effects.9 Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir, GlaxoSmithKline.
    Glaxo Smith Kline reacted ____13____ the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.
    The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries. They plan in the next few months to ask the United States Food and Drug Administration10 to ____14____ the new pill.
    There are limits to who could take it because of the different drugs it contains. For example, ____15____ women are told not to take Sustiva because of the risk of birth disorders.11 Experts say more than forty million people around the world are living with H.I.V.
    詞匯:
    malaria n. 瘧疾
    tuberculosis n. 結(jié)核(病)
    joint adj. 聯(lián)合的,共同的
    suppress vt. 抑制
    pregnant adj. 妊娠的,有孕的
    注釋:
    1. HIV ( human immunodeficiency virus ):人免疫缺陷病毒
    2. AIDS ( acquired immunodeficiency syndrome ):獲得性免疫缺陷綜合征,艾滋病
    3. (be / come)on the market:出售
    4. Sustiva以及后面出現(xiàn)的Emtriva、Viread和Combivir都是治療艾滋病藥物的商品名。
    5. New England Journal of Medicine:新英格蘭醫(yī)藥雜志。New England 是美國東北六州( Maine, Vermont, New Hampshire, Massachusetts, Rhode Island 和 Connecticut )的總稱。
    6. 英國英語中compare with是“與…相比較”的意思,compare to是“把...比作...” 的意思,但在美國英語中compare to也有compare with的意思,這里就是“把...與…相比較”的意思。
    7. AZT (Azidothymidine ):疊氨胸苷(能抑制引起艾滋病的人免疫缺陷病毒)
    8. 3TC:拉夫米定(一種胞嘧啶核苷衍生物,能抑制乙肝病毒和人免疫缺陷病毒的逆轉(zhuǎn)錄酶的活性,改善肝臟組織的病變)
    9. side effect:副作用
    10. United States Food and Drug Administration (FDA):美國食品與藥品管理局
    11. birth disorder:先天性疾病
    練習(xí):
    1. A) conservation B) cooperation C) combinations D) considerations
    2. A) simpler B) more complex C) more meaningless D) more troublesome
    3. A) starting B) stopping C) ending D) discontinuing
    4. A) analyzed B) examined C) explored D) developed
    5. A) before B) after C) under D) above
    6. A) one B) ones C) other D) others
    7. A) social B) technical C) personal D) historical
    8. A) if B) as if C) though D) as though
    9. A) that B) which C) what D) whatever
    10. A) size B) shape C) appearance D) effectiveness
    11. A) excludes B) contains C) looks like D) tastes of
    12. A) few B) fewer C) many D) more
    13. A) for B) with C) to D) into
    14. A) prove B) disprove C) improve D) approve
    15. A) weak B) strong C) elder D) pregnant
    完型填空答題思路:
    1. 分析文章標(biāo)題, 了解文章主題, 確認(rèn)文章主題詞;
    2. 對比被選項(xiàng), 判斷可能考點(diǎn);
    3. 關(guān)注空格兩端結(jié)構(gòu),借助空格所在的局部搭配結(jié)構(gòu)及搭配語意判斷答案;
    答案與解析:
    1. 分析文章主題:
    Once-daily(每天一次) pill(藥丸) could simplify(簡單化) HIV(艾滋病病毒) treatment(治療)
    文章主題詞:pill, simplify, HIV, treatment
    2. 直接解題:
    Myers Squibb and Gilead Sciences have combined many H.I.V. drugs into (把...合成...)a single(單一的, 單身的,一個(gè),挑出) pill. Sometimes(有時(shí)) the best medicine(藥) is more than (多于...,)one kind(種類, 仁慈的, 和藹的) of medicine.
    1. A) conservation(保存, 保持) B) cooperation(合作)
    C) combinations(結(jié)合,聯(lián)合, 組合物) D) considerations (考慮,需要考慮的事情)
    Malaria(瘧疾), tuberculosis(肺結(jié)核) and H.I.V./AIDS(艾滋病), for example(例如), are all treated(被治療) with(用, 由于, 贊成) ____1____ of drugs.
    1. C 空格前句中出現(xiàn)了被選項(xiàng)C的家族詞匯combine,因此C成為答案的可能性較大(提示1:出現(xiàn)文章主題詞或出現(xiàn)與文章主題詞呼應(yīng)的近義詞/家族詞匯的選項(xiàng)可能是答案)。如果把C填入空格中, 則空格所在的局部結(jié)構(gòu)說“...被用組合藥進(jìn)行治療 ”, 該結(jié)構(gòu)意義通順,因此C是答案。
    考點(diǎn):上下文意義的銜接(家族詞匯的呼應(yīng))
    But that can mean(意味著, 想要, 吝嗇的, 平均的) a lot of(許多的) pills to take(服用,拿走, 獲得, 占領(lǐng)).
    2. A) simpler(更簡單的, 更樸素的) B) more complex(更復(fù)雜的)
    C) more meaningless(更無意義的) D) more troublesome(更討厭的, 更麻煩的)
    It would be ____2____ if drug companies(公司) combined all the medicines into a single pill, which is taken(被服用) just once a day(一天一次).
    2. A 被選項(xiàng)A中的核心詞simpler是文章主題詞simplify的家族詞匯, 因此A成為答案的可能性較大。
    考點(diǎn):文章主題。
    3. A) starting(開始,出發(fā)) B) stopping(停止, 停下來)
    C) ending(結(jié)束, 結(jié)尾) D) discontinuing (停止, 放棄)
    Now(現(xiàn)在), two companies(公司) say they have done that (已經(jīng)...)for people just(僅僅,剛剛, 剛好, 公正的,正確的) ____3____ treatment for H.I.V., the virus(病毒) that causes(造成) AIDS(艾滋病).
    3. A 被選項(xiàng)B, C和D在“停止”這層詞義上互為近義詞,因此彼此排除掉, 所以答案為A。
    考點(diǎn):復(fù)合句。
    The companies(公司) are Bristol-Myers Squibb and Gilead Sciences.
    4. A) analyzed(分析) B) examined(檢查, 考試)
    C) explored(探險(xiǎn), 探測, 研究) D) developed (發(fā)展, 生長,研制)
    They have ____4____ a single pill that combines(合成, 聯(lián)合) three drugs currently(現(xiàn)在) on the market(出售).
    4. D 空格所在的句子說“他們已經(jīng)...一個(gè)藥丸, 該藥丸把現(xiàn)在市場上在出售的三種藥合成在一起”,上文提到“有兩家公司已經(jīng)在進(jìn)行把治療艾滋病的多種藥合成一種藥的工作” , 因此空格處出現(xiàn)“開發(fā),研發(fā)”(D項(xiàng))恰當(dāng)。
    考點(diǎn):上下文之間的意義關(guān)系。
    5. A) before(在...之前) B) after(在...之后,以...而命名 /name...after.../以...的名字而命名)
    C) under (在...之下, 在...領(lǐng)導(dǎo)下,在...狀態(tài)中) D) above(在...上方, 在上面, 上面的)
    Bristol-Myers Squibb sells(出售) one of them ____5____ the name of Sustiva.4
    5. C 這幾個(gè)介詞中,只有under可以與name組合成短語under the name of (“以…名,名為…”),其它選項(xiàng)在這里均不合適。
    考點(diǎn):固定搭配短語結(jié)構(gòu)(介詞短語結(jié)構(gòu))。
    6. A) one(一, 一個(gè),任何人) B) ones
    C) other(其他的,其他人) D) others(其他人, some...others...一些...一些...)
    Gilead combined the ____6____, Emtriva and Viread, into a single pill in two thousand four.
    6. D 上面提到兩家公司已經(jīng)開發(fā)出將多種藥合成為單片的新藥,Myers公司已合成了一種,Gilead公司則于2004年將其它兩種Emtriva和Viread合成為單片,這里既然列出了這兩種藥的名稱,所以就必須用“others”。
    考點(diǎn):上下文之間的意義關(guān)系,篇章短語結(jié)構(gòu)one ... the others...一個(gè)...其他的...
    7. A) social(社會(huì)的,愛社交的) B) technical (技術(shù)的)
    C) personal(個(gè)人的, 私人的, 親自的) D) historical(歷史的, 有關(guān)歷史的)
    Combining(合成的, 化合的) drugs involves(包括, 使陷于) more than ____7____ issues(問題).
    7. B 空格所在的句子說“合成藥不僅僅涉及到...的問題”, 根據(jù)常識判斷“合成藥首先應(yīng)該是技術(shù)方面的問題”,因此B(技術(shù)的)是答案。
    8. A) if(如果,是否) B) as if (好像)
    C) though (雖然, 盡管) D) as though(好像)
    It also involves(包括,使陷于) issues of competition(競爭) ____8____ the drugs are made(被生產(chǎn)) by different(不同的) companies(公司).
    8. A 被選項(xiàng)B和D互為近義詞, 因此彼此排除掉。剩下的選項(xiàng)都可引導(dǎo)狀語從句, 因此關(guān)注空格所在的從句與主句之間意義關(guān)系。 句子主句說“它也涉及到競爭方面的問題”, 從句說“藥品由不同的廠家生產(chǎn)”, 顯然從句與主句之間是“條件”與“結(jié)果”之間的關(guān)系,因此if(如果)合適。
    考點(diǎn):狀語從句
    9. A) that B) which
    C) what(什么, ...的) D) whatever(無論什么,無論哪一種的)
    The new(新的) once-daily pill(藥丸) is the result(結(jié)果,造成,起因(于)) of ____9____ is described as (被描述為...)the first joint venture (合資) agreement(協(xié)議,同意) of its kind (種類, 仁慈的)in(在...的過程中,) the treatment(治療) of H.I.V.
    9. C the result of后面出現(xiàn)的應(yīng)該是一個(gè)賓語從句,且空白處的連接詞應(yīng)該充當(dāng)賓語從句的主語,首先我們可以排除that(that引導(dǎo)名詞性從句時(shí),that在從句中不充當(dāng)任何語法成分,僅僅起一個(gè)連接從句的作用 )和which(which引導(dǎo)名詞性從句時(shí), which后常常會(huì)帶有一個(gè)單數(shù)的名詞),因此答案只能來自C和D。這兩個(gè)選項(xiàng)的差別是what是特指,而whatever是泛指。空格所在的句子說“這種新的每天服一次的藥丸被描述成在治療HIV病毒的過程中所達(dá)成的第一個(gè)合資協(xié)議的產(chǎn)物”,這是特指,不是泛指, 因此what是答案。
    考點(diǎn):賓語從句(區(qū)分what 與whatever)
    In January(一月) the New England (新英格蘭)Journal(雜志) of Medicine(藥,醫(yī)學(xué)))published(出版, 公布, 發(fā)表) a study(研究,學(xué)習(xí)) of the new pill.
    10. A) size(大小,尺寸) B) shape(形狀, 使成形)
    C) appearance(出現(xiàn),外觀) D) effectiveness (效用)
    Researchers(研究者) compared(比較) its(the new pill) ____10____ to that of the widely(廣泛地,普遍地) used(被使用的, 用舊的) combination(合成物) of Sustiva and Combivir.